aTyr Pharma ATYR Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -40,856.3%-11,957pp | -28,899.6%-13,342pp | -15,557.8%— | —— | |
| Net margin | -39,009.5%-11,766pp | -27,243.8%-12,969pp | -14,274.5%— | —— | |
| Returns | |||||
| Return on equity | -107.8%-28.1pp | -79.7%-17.5pp | -62.2%-12.0pp | -50.2%-2.2pp | |
| Return on invested capital | -109.2%-22.6pp | -86.6%-18.0pp | -68.6%-18.3pp | -50.3%+4.0pp | |
| Efficiency | |||||
| Asset turnover | 0×0.0× | 0×0.0× | 0×— | —— | |
| Liquidity | |||||
| Current ratio | 5.3×-0.2× | 5.5×-0.8× | 6.3×+0.4× | 5.8×-13.1× | |
| Leverage | |||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×+0.2× | |
| Per Share | |||||
| Book value per share | $0.73-23.0% | $0.94-44.2% | $1.69-32.7% | $2.51-56.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do aTyr Pharma's ratios come from?
- Every ratio is computed from aTyr Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
